Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Organovo Holdings, Inc. (ONVO) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Organovo Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1497253.
Total stock buying since 2014: $652,801.
Total stock sales since 2014: $1,357,785.
Total stock option exercises since 2014: $173,584.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 19,607 | $31,743 | 0 | $0 |
| 2021 | 10,750 | $72,315 | 0 | $0 | 0 | $0 |
| 2019 | 0 | $0 | 22,230 | $6,424 | 0 | $0 |
| 2018 | 0 | $0 | 40,000 | $50,800 | 0 | $0 |
| 2017 | 335,500 | $501,306 | 50,000 | $179,688 | 30,000 | $30,000 |
| 2016 | 0 | $0 | 70,000 | $276,950 | 0 | $0 |
| 2015 | 30,000 | $79,180 | 6,000 | $24,192 | 50,000 | $4,000 |
| 2014 | 0 | $0 | 115,000 | $787,988 | 68,474 | $139,584 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 0 | $0 | 19,607 | $31,743 | 0 | $0 |
| 2021-08 | 10,750 | $72,315 | 0 | $0 | 0 | $0 |
| 2019-08 | 0 | $0 | 22,230 | $6,424 | 0 | $0 |
| 2018-11 | 0 | $0 | 40,000 | $50,800 | 0 | $0 |
| 2017-11 | 335,500 | $501,306 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 25,000 | $92,025 | 30,000 | $30,000 |
| 2017-01 | 0 | $0 | 25,000 | $87,663 | 0 | $0 |
| 2016-12 | 0 | $0 | 50,000 | $185,950 | 0 | $0 |
| 2016-08 | 0 | $0 | 20,000 | $91,000 | 0 | $0 |
| 2015-09 | 0 | $0 | 6,000 | $24,192 | 0 | $0 |
| 2015-08 | 30,000 | $79,180 | 0 | $0 | 0 | $0 |
| 2015-03 | 0 | $0 | 0 | $0 | 50,000 | $4,000 |
| 2014-12 | 0 | $0 | 35,000 | $263,518 | 0 | $0 |
| 2014-10 | 0 | $0 | 50,000 | $305,500 | 0 | $0 |
| 2014-09 | 0 | $0 | 30,000 | $218,970 | 0 | $0 |
| 2014-08 | 0 | $0 | 0 | $0 | 18,474 | $57,084 |
| 2014-05 | 0 | $0 | 0 | $0 | 50,000 | $82,500 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-15 | Gobel David | Sale | 19,607 | 1.62 | 31,743 |
| 2021-08-17 | Cohen Douglas Jay (Director) | Buy | 10,750 | 6.73 | 72,315 |
| 2019-08-16 | Hughes Steven George (Chief Medical Officer) | Sale | 22,230 | .29 | 6,424 |
| 2018-11-08 | Presnell Sharon Collins (Chief Scientific Officer) | Sale | 40,000 | 1.27 | 50,800 |
| 2017-11-24 | Murphy Keith (Other) | Buy | 200,500 | 1.49 | 299,346 |
| 2017-11-22 | Murphy Keith (Other) | Buy | 135,000 | 1.50 | 201,960 |
| 2017-02-09 | Murphy Keith (Chairman, CEO and President) | Sale | 25,000 | 3.68 | 92,025 |
| 2017-02-08 | Murphy Keith (Chairman, CEO and President) | Option Ex | 30,000 | 1.00 | 30,000 |
| 2017-01-24 | Murphy Keith (Chairman, CEO and President) | Sale | 20,100 | 3.50 | 70,450 |
| 2017-01-23 | Murphy Keith (Chairman, CEO and President) | Sale | 4,900 | 3.51 | 17,213 |
| 2016-12-14 | Murphy Keith (Chairman, CEO and President) | Sale | 50,000 | 3.72 | 185,950 |
| 2016-08-05 | David Eric (CSO & EVP Pre-Clinical Dev) | Sale | 20,000 | 4.55 | 91,000 |
| 2015-09-21 | Baltera Robert Jr. (Director) | Sale | 6,000 | 4.03 | 24,192 |
| 2015-08-13 | Glover James T (Director) | Buy | 10,000 | 2.80 | 28,000 |
| 2015-08-12 | Murphy Keith (Chairman, CEO and President) | Buy | 20,000 | 2.56 | 51,180 |
| 2015-03-12 | Presnell Sharon Collins (EVP, Research & Dev & CTO) | Option Ex | 50,000 | .08 | 4,000 |
| 2014-12-30 | David Eric (Chief Strategy Officer) | Sale | 16,300 | 7.56 | 123,244 |
| 2014-12-30 | Michaels Barry D (Chief Financial Officer) | Sale | 10,500 | 7.50 | 78,771 |
| 2014-12-29 | David Eric (Chief Strategy Officer) | Sale | 3,700 | 7.50 | 27,753 |
| 2014-12-29 | Michaels Barry D (Chief Financial Officer) | Sale | 4,500 | 7.50 | 33,750 |
| 2014-10-06 | Presnell Sharon Collins (EVP, Research & Dev & CTO) | Sale | 50,000 | 6.11 | 305,500 |
| 2014-09-12 | David Eric (Chief Strategy Officer) | Sale | 30,000 | 7.30 | 218,970 |
| 2014-08-26 | Michaels Barry D (Chief Financial Officer) | Option Ex | 18,474 | 3.09 | 57,084 |
| 2014-05-08 | Renard Michael (EVP of Commercial Operations) | Option Ex | 50,000 | 1.65 | 82,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of ONVO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Organovo Holdings, Inc. (symbol ONVO, CIK number 1497253) see the Securities and Exchange Commission (SEC) website.